Latest news
FIVE9, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $35 FROM $23 - BitgetBitget · Fri, 07 Aug 2026 21:21:39 GMTTruist raises RXO price target to $28 after str... - pluang.compluang.com · Fri, 07 Aug 2026 17:53:50 GMTZYME Maintained by Truist Securities -- Price Target Raised to $32.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 16:34:03 GMTHRTG Maintains Rating by Truist Securities -- Price Target Raised to $42 - GuruFocusGuruFocus · Fri, 07 Aug 2026 15:27:28 GMTNET Maintained by Truist Securities -- Price Target Raised to $3 - GuruFocusGuruFocus · Fri, 07 Aug 2026 15:21:51 GMTCLIMB BIO INC : TRUIST SECURITIES RAISES TARGET PRICE TO $25 FROM $17 - BitgetBitget · Fri, 07 Aug 2026 12:28:09 GMTENCOMPASS HEALTH CORP : TRUIST SECURITIES RAISES TARGET PRICE TO $150 FROM $140 - BitgetBitget · Fri, 07 Aug 2026 03:33:38 GMTTruist Financial Raises Dianthus Therapeutics (NASDAQ:DNTH) Price Target to $128.00 - MarketBeatMarketBeat · Thu, 06 Aug 2026 17:25:02 GMT